Redox influence on the inflammatory response in rheumatoid arthritis;Influência de processos redox na resposta inflamatória da artrite reumatóide

Revista Brasileira de Reumatologia

Volumn 48, Issue 1, 2008, Pages 17-24

  Filippin, Lidiane Isabel ^a   Vercelino, Rafael ^b   Marroni, Norma Possa ^c   Machado Xavier, Ricardo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fisiologia Humana pela UFRGS   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Imflammation; Oxidative stress; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; NUCLEIC ACID; PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTHROPATHY; GENE EXPRESSION; INFLAMMATION; MEMBRANE DAMAGE; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PHAGOCYTE; RESPIRATORY BURST; REVIEW; RHEUMATOID ARTHRITIS; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 52049109674     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Avalos I, Chung CP, Oeser A, et al.: Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 16(3): 195-200, 2007.
2. Surh YJ: Oxidative Stress, Inflammation, and Health. Packer L (ed.). Londres: Taylor & Francis, 2005.
3. Kinne RW, Bräuer R, Stuhlmüller B, et al.: Macrophages in rheumatoid arthritis. Arthritis Res 2(3): 189-202, 2000.
4. Altindag O, Karakoc M, Kocyigit A, et al.: Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 40(3-4): 167-71, 2007.
5. Senna ER, De Barros AL, Silva EO, et al.: Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31(3): 594-7, 2004.
6. Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet 358(9285): 903-11, 2001.
7. Ozkan Y, Yardým-Akaydýn S, Sepici A, Keskin E, Sepici V, Simsek B: Oxidative status in rheumatoid arthritis. Clin Rheumatol 26(1): 64-8, 2007.
8. Sies H: Oxidative Stress: Introdutory remaks. v.1. London: Academic Press, 1985. p. 1-8.
9. Jones DP: Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact 163(1-2): 38-53, 2006.
10. Forman HJ, Fukuto JM, Torres M: Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287(2): C246-56, 2004.
11. Rosa RM, Roehrs R, Saffi J, Henriques JAP: "O papel da reparação de lesões oxidativas induzidas no DNA na redução do risco de desenvolvimento de câncer". In: Salvador M, Henriques JAP. (Orgs.). Radicais livres e a resposta celular ao estresse oxidativo. 1.ed. Canoas: Editora da Ulbra, 2004.
12. Andreoli TE, Carpenter CCJ, Benett JC, Plum F: Medicina Interna Básica. 4.ed. Rio de Janeiro: Guanabara Koogan, 1997. p. 568-70.
13. Vignaud A, Cebrian J, Martelly I, Caruelle JP, Ferry A: Effect of anti-inflammatory and antioxidant drugs on the long-term repair of severely injured mouse skeletal muscle. Exp Physiol 90(4): 487-95, 2005.
14. Henrotin Y, Kurz B, Aigner T: Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage 13(8): 643-54, 2005.
15. Fang YZ, Yang S, Wu G: Free radicals, antioxidants, and nutrition. Nutrition 18(10): 872-9, 2002.
16. Hitchon CA, HS El- Gabalawy: Oxidation in rheumatoid arthritis. Arthritis Res Ther 6(6): 265-78, 2004.
17. Belló-Klein A, Llesuy SF: Estresse Oxidativo e Antioxidantes. Canoas: Ulbra, 2002. p. 15-19; 21-32.
18. Halliwel B, Gutteridge JCM: Free Radicals in Biology and Medicine. 3.ed. Londres: Oxford University Press, 1999.
19. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 82(1): 47-95, 2002.
20. Oktyabrsky ON, Smirnova GV: Redox regulation of cellular functions. Biochemistry (Mosc) 72(2): 132-45, 2007.
21. Griffiths HR: ROS as signalling molecules in T cells - evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep 10(6): 273-80, 2005.
22. Barry Halliwell JG: Free Radicals in Biology and Medicine. 4.ed. New York: Oxford University Press, 2007.
23. Bitencoutt PIH: Metabolismo do Ácido Araquidômico na Sepse, in Sepse. Manole, São Paulo, 2007.
24. Hwang ES, Kim GH: Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 229(1-2): 1-10, 2007.
25. Okamoto T, Sakurada S, Yang JP, Merin JP: Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. Curr Top Cell Regul 35: 149-61, 1997.
26. Kim WU, Yoo SA, Min SY, et al.: Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin Exp Immunol 144(3): 503-11, 2006.
27. Blair IA: Endogenous glutathione adducts. Curr Drug Metab 7(8): 853-72, 2006.
28. Soneja A, Drews M, Malinski T: Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep 57 Suppl: 108-19, 2005.
29. Fritz R, Bol J, Hebling U, et al.: Compartment-dependent management of H(2)O(2) by peroxisomes. Free Radic Biol Med 42(7): 1119-29, 2007.
30. Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J: Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem. 279(26): 26839-45, 2004.
31. Del Rio D, Stewart AJ, Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15(4): 316-28, 2005.
32. Montuschi P, Barnes PJ, Roberts 2nd LJ: Isoprostanes: markers and mediators of oxidative stress. Faseb J 18(15): 1791-800, 2004.
33. Montuschi P, Barnes P, Roberts 2nd LJ: Insights into oxidative stress: the isoprostanes. Curr Med Chem 14(6): 703-17, 2007.
34. Cracowski JL, Marpeau C, Carpentier PH, et al.: Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. Arthritis Rheum 44(5): 1143-8, 2001.
35. Lushchak V, Semchyshyn H, Mandryk S, Lushchak O: Possible role of superoxide dismutases in the yeast Saccharomyces cerevisiae under respiratory conditions. Arch Biochem Biophys 441(1): 35-40, 2005.
36. Moynagh PN: The NF-kappaB pathway. J Cell Sci 118(Pt 20): 4589-92, 2005.
37. Goldring SR: Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 14(4): 406-10, 2002.
38. Miossec P: An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16(3): 218-22, 2004.
39. Grootveld M, Henderson EB, Farrell A, Blake DR, Parkes HG, Haycock P: Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J 273(Pt 2): 459-67, 1991.
40. Taysi S, Polat F, Gul M, Sari RA, Bakon E: Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21(5): 200-4, 2002.
41. Dai L, Polat F, Gul M, Sari RA, Bakan E: Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid arthritis patients. Free Radic Res 32(6): 479-86, 2000.
42. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R: Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329(1-2): 23-38, 2003.
43. Jikimoto T, Nishikubo Y, Koshiba M, et al.: Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 38(10): 765-72, 2002.
44. Khan F, Siddiqui AA: Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin Chim Acta 370(1-2): 100-7, 2006.
45. Zugel U, Kaufmann SH: Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 12(1): 19-39, 1999.
46. Cronstein BN: Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57(2): 163-72, 2005.
47. Sung JY, Hong JH, Kang HS, et al.: Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology. 47(1): 35-44, 2000.
48. Laurindo IM, Mello SB, Cossermelli W: Influence of low doses of methotrexate on superoxide anion production by polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Rheumatol 22(4): 633-8, 1995.
49. Mangge HJ, Hermann J, Schauenstein K: Diet and rheumatoid arthritis - a review. Scand J Rheumatol 28(4): 201-9, 1999.
50. den Broeder AA, Wanten GJ, Oyen WJ, Naber T, van Riel PL, Barrera P: Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis. J Rheumatol 30(2): 232-7, 2003.
51. Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A: Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis. Rheumatol Int, 28(3): 245-51, 2008.
52. Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA: Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 157(4): 345-54, 2003.
53. Hagfors L, Leanderson P, Sköldstam L, Anderson J, Johansson G: Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2: 5, 2003.
54. Bar-Shai M, Reznick AZ: Peroxynitrite induces an alternative NF-kappaB activation pathway in L8 rat myoblasts. Antioxid Redox Signal 8(3-4): 639-52, 2006.
55. Bar-Shai M, Reznick AZ: Reactive nitrogen species induce nuclear factor-kappaB-mediated protein degradation in skeletal muscle cells. Free Radic Biol Med 40(12): 2112-25, 2006.